Corcept Therapeutics (CORT) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.17 --0%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.32 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
